scispace - formally typeset
W

Wolfgang Weidenhammer

Researcher at Technische Universität München

Publications -  88
Citations -  4479

Wolfgang Weidenhammer is an academic researcher from Technische Universität München. The author has contributed to research in topics: Acupuncture & Randomized controlled trial. The author has an hindex of 26, co-authored 88 publications receiving 4244 citations. Previous affiliations of Wolfgang Weidenhammer include Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

A multicenter survey of amalgam fillings and subjective complaints in non‐selected patients in the dental practice

TL;DR: A higher number of symptoms as well as a higher intensity of symptoms were found in patients before amalgam removal compared to the remaining patients, and the question remains open whether or not there may be a certain kind of relationship between the complaints and amalgam fillings in individual patients.
Journal ArticleDOI

Treatment of patients with chronic headaches in a hospital for traditional Chinese medicine in Germany. A randomised, waiting list controlled trial.

TL;DR: Treatment in the hospital for traditional Chinese medicine in Kotzting is associated with lasting improvements in the majority of patients, and patients with migraine and a combination of migraine and episodic tension-type headaches improved more than patients with other headaches.
Journal ArticleDOI

Monitoring of liver enzymes in patients treated with traditional Chinese drugs.

TL;DR: In the population and setting studied, clinically relevant liver enzyme elevations occurred in about 1/100 patients treated with traditional Chinese drugs.
Journal ArticleDOI

Acupuncture for osteoarthritic pain: an observational study in routine care

TL;DR: In this study, patients with chronic pain due to osteoarthritis reported clinically relevant improvements after acupuncture treatment, and Statistically significant and clinicallyrelevant improvements were seen in all subgroups both after treatment and at 6 months in all major outcome measures.